Patents by Inventor Nimmerjahn Falk

Nimmerjahn Falk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
    Patent number: 10167332
    Abstract: The invention provides a polypeptide containing at least one IgG Fc region region, said polypeptide having a higher anti-inflammatory activity and a lower cytotoxic activity as compared to an unpurified antibody and methods of production of such polypeptide.
    Type: Grant
    Filed: April 3, 2007
    Date of Patent: January 1, 2019
    Assignee: The Rockefeller University
    Inventors: Jeffrey V. Ravetch, Yoshikatsu Kaneko, Nimmerjahn Falk
  • POLYPEPTIDES WITH ENHANCED ANTI-INFLAMMATORY AND DECREASED CYTOTOXIC PROPERTIES AND RELATING METHODS
    Publication number: 20100278808
    Abstract: The invention provides a polypeptide containing at least one IgG Fc region region, said polypeptide having a higher anti-inflammatory activity and a lower cytotoxic activity as compared to an unpurified antibody and methods of production of such polypeptide.
    Type: Application
    Filed: April 3, 2007
    Publication date: November 4, 2010
    Inventors: Jeffrey V. Ravetch, Yoshikatsu Kaneko, Nimmerjahn Falk